NEW DELHI, 9 JUNE: India is going all out to monitor global ban on drugs. The Drug Controller General of India (DCGI) has ordered the setting up of a new special cell in the Central Drug Standard Control Organization (CDSCO) that will monitor the fate of drugs being sold both abroad and back home.
India has always been blamed for allowing the sale of drugs that are banned in other countries for proven adverse effects.
DCGI Dr Surinder Singh's order, however, promises to buck the trend. An assistant drug controller will head the cell, and it will be operational from June 15.
Dr Singh told this reporter, "India should not be caught napping when it comes to banning drugs that have been banned by other countries. We should know which drugs are getting banned and come to know of it as soon as the announcement is made. The cell will closely follow the regulatory status of all drugs being sold globally and in the domestic market."
It will monitor all drugs globally, restrictions being placed on them, alerts issued about their side-effects, announcements made on their restrictions, box warnings and the ones that are being removed from the market.
Dr Singh added, "The cell will be in close contact with international regulatory organizations like the USFDA, MHRA (UK) and TGA (Australia)."
DGCI recently imposed a ban on the sale of some drugs and around 250 formulations of these drugs, including cisapride, R-sibutramine, nimesulide, sibutramine and phenylpropalamine. |
No comments:
Post a Comment